Margaret Anne Butlin

Title: The Innovations of Margaret Anne Butlin

Introduction

Margaret Anne Butlin is a notable inventor based in Macclesfield, GB. She has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. Her work has led to the creation of innovative solutions that address various medical needs.

Latest Patents

Margaret holds a patent for a compound titled "Protected forms of N-(3-methoxy-5-methylpiperazin-2-yl)-2-(4-[1,3,4,-oxadiazol-2-yl]phenyl)-pyridine-3-sulphonamide." This invention relates to compounds where P is a nitrogen-protecting group, along with processes for preparing these compounds. Her patent demonstrates her expertise in the synthesis of complex chemical structures.

Career Highlights

Margaret is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca has allowed her to work on groundbreaking research and development projects that aim to improve patient outcomes. With her innovative mindset, she has contributed to the advancement of pharmaceutical sciences.

Collaborations

Margaret has collaborated with esteemed colleagues, including Roger John Butlin and Philip John Hogan. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Margaret Anne Butlin's contributions to the field of chemistry and her innovative patents highlight her as a prominent figure in the pharmaceutical industry. Her work continues to inspire future generations of inventors and researchers.